Erythromycin stearate - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for erythromycin stearate and what is the scope of patent protection?

Erythromycin stearate is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Azurity, Ani Pharms, Lederle, Norvium Bioscience, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for erythromycin stearate.

Sponsor

Phase

Chr Hansen A/S

N/A

Chr Hansen

N/A

Ryerson University

N/A

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061461-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Purepac Pharm	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061743-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	062121-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	ERYPAR	erythromycin stearate	TABLET;ORAL	062032-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061505-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lederle	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	062089-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061461-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	8
Applicants:	12
NDAs:	15
Drug Master File Entries:	18
Raw Ingredient (Bulk) Api Vendors:	128
Clinical Trials:	1
Patent Applications:	7,511
Drug Prices:	Drug price trends for erythromycin stearate
What excipients (inactive ingredients) are in erythromycin stearate?	erythromycin stearate excipients list
DailyMed Link:	erythromycin stearate at DailyMed